Manufacturer record

Pushkar Pharma: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

12 batches manufactured by Pushkar Pharma (Himachal Pradesh) were declared Not of Standard Quality between April 2020 and June 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

12 records linked to Pushkar Pharma in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
12Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Apr 2020 to Jun 2025

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

12
NSQ batches since 2020
9
Products affected
Assay
Most common failure
Jun 2025
Latest alert

Flagged batches per year

2020 · 12021 · 32022 · 32023 · 12024 · 12025 · 3

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Clotrimazole Ear Drops CLT-214AMfg 2024-08 · Exp 2026-07 Assay of ClotrimazoleAssay CDL KolkataCDSCO lab Jun 2025
Amoxycillin and Potassium Clavulanate Injection IP ACP-738AMfg 2023-09 · Exp 2025-08 Assay of Potassium Clavulanate equivalent to Clavulanic AcidAssay CDL KolkataCDSCO lab Jun 2025
Phenytoin Sodium Injection USP PTS-225AMfg 2024-05 · Exp 2026-04 Alcohol Content and Propylene Glycol contentOther CDL KolkataCDSCO lab Feb 2025
Oxytocin Injection I.P. 5 IU/1 ml OTC-382AMfg 2023-04 · Exp 2025-03 Description, Particulate matter & Assay of OxytocinAssay CDL KolkataCDSCO lab Sep 2024
Enrofloxacin Injection IP (Vet.) VENF-250AMfg 2022-01 · Exp 2023-12 pHpH RDTL ChandigarhState lab Apr 2023
MIDAZOLAM INJECTION IP MDM-155AMfg 2022-03 · Exp 2024-02 pH and AssayAssay RDTL ChandigarhState lab Oct 2022
Gentamicin Injection I.P. (Vet) ? 30 ml VGTA-108AMfg 2021-12 · Exp 2023-11 Description and Particulate MatterDescription CDL KolkataCDSCO lab Aug 2022
PHENYTOIN SODIUM INJECTION USP PTS-155AMfg 2021-10 · Exp 2023-09 pHpH RDTL ChandigarhCDSCO lab Feb 2022
OXYTOCIN INJECTION IP OTC-233AMfg 2021-02 · Exp 2022-07 Assay of Oxytocin ActivityAssay RDTL ChandigarhState lab Sep 2021
Budesonide Nebuliser Suspension BP (0.5 mg/2 ml) (BUDELIFE RESPULES OTC-256AMfg 2021-04 · Exp 2022-09 Assay of BudesonideAssay RDTL ChandigarhState lab Sep 2021
OXYTOCIN INJECTION I.P. OTC-232AMfg 2021-02 · Exp 2022-07 Assay of Oxytocin ActivityAssay RDTL ChandigarhState lab Aug 2021
Lignocaine With Adrenaline Injection IP LAN-113AMfg 2019-07 · Exp 2020-12 Assay of Adrenaline BitartrateAssay RDTL ChandigarhCDSCO lab Apr 2020

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.